WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications

Testing of drug candidate WP1122 to be done by leading Government funded research institution specializing in infectious diseases including COVID-19   Vancouver, BC – March 24, 2020 – WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical stage pharmaceutical company, announces it has entered into a development agreement (the “Agreement”) with CNS […]

Sustained Growth is Projected for Oil and Gas Companies in Indonesia

Palm Beach, FL – March 24, 2020 – Oil and gas production has a long history in Indonesia, with Indonesia being an international pioneer in many areas, however, the industry has not seen significant new developments for a number of years, with many existing contractors having lost interest in further exploration in Indonesia due to […]

Biotech Brief: Why Oncolytic Viruses Are Becoming A Potent Weapon Against Cancer

Palm Beach, FL –March 24, 2020 – Oncolytic viruses are becoming a new class of cancer immunotherapy weapons to combat cancer. These naturally occurring or modified viruses are a potent new weapon against cancer, according to recent reports on this growing market. The reports actually reveal that: “… since the late 1800s, doctors have observed […]

Oncolytics Biotech® Announces Favorable AWARE-1 Safety Update

Study continues enrollment in patients receiving Tecentriq combination   Clinical data to be presented at ESMO Breast in May   San Diego, CA and Calgary, AB – March 24, 2020 — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced a favourable assessment from the Safety Committee […]